3-((E)-3-Phenyl-2-propenoyl)-1,3-oxazolidin-2-one, 97%, 1g

ETHYL 7-OXOSPIRO[3.5]NONANE-6-CARBOXYLATE, 95.0%, 250mg

2-Chloro-6-methyl-3-nitropyridine, 97.0%, 5g

DL-alpha-Lipoic Acid-NHS>96.0%(HPLC)250mg

2-(2-((4-Chlorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

4-Ethoxy-3,5-difluorophenylboronic acid, 97%, 5g

Dicyclohexano-18-crown 6-Ether>98.0%(GC)1g

2-(Dimethylamino)ethyl Methacrylate (stabilized with MEHQ)>98.5%(GC)25mL

1-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 10g

2-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)ethan-1-amine, 95%, 100mg

(R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)acetic acid, 95.0%, 10g

(R)-3-(1-Aminoethyl)-4-fluorobenzonitrile, 98%, 250mg

7-Bromo-2,3-dichloropyrido[2,3-b]pyrazine, 98%, 250mg